Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless cervical cancer detection test based on its patented biophotonic technology, announced that it will meet with the FDA to finalize the protocol for its clinical study in support of its...
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless cervical cancer detection test based on its patented biophotonic technology, announced today that it had submitted its protocol to FDA for a clinical study to support marketing of the LuViva®...
Guided Therapeutics Successfully Uplists to Over the Counter Venture Market from Pink Sheets Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that its common stock...
Guided Therapeutics LuViva Advanced Cervical Scan Awarded New CE Mark with Expanded Claims Company Partners with Newmars Technologies, Kft. for Cost Effective Contract Manufacturing in Hungary Guided Therapeutics, Inc. (Pink Sheets: GTHP), the maker of a rapid and...
Guided Therapeutics Announces Completion of a $1.5 Million Financing to Accelerate 2020 Business Plan Guided Therapeutics, Inc. (Pink Sheets: GTHP), the maker of a rapid and painless cervical cancer detection test based on its patented biophotonic technology,...
